Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2 diabetes: a systematic review and meta-analysis - Eng, C; Kramer, C K; Zinman, B (Lancet, 2014)
. doi:10.1016/S0140-6736(14)61335-0